Gu Yoshiaki, Fujitomo Yumiko, Ohmagari Norio
Department of Infectious Diseases, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
AMR Clinical Reference Center, National Center for Global Health and Medicine Hospital, Tokyo 162-8655, Japan.
Antibiotics (Basel). 2021 Oct 22;10(11):1293. doi: 10.3390/antibiotics10111293.
The threat from antimicrobial resistance (AMR) continues to grow. Japan's National Action Plan on Antimicrobial Resistance, which was formulated in 2016 and targets six areas, has already had a major impact on the countermeasures implemented against AMR. Particular advances have been made in AMR-related surveillance, and we now know the situation regarding antimicrobial use and antimicrobial-resistant bacteria in the country. Educational and awareness-raising activities for medical professionals and the general public have been actively implemented and seem to have contributed to a gradual move toward an appropriate use of antimicrobials. However, there is still insufficient understanding of the issue among the general public. Determining how to use surveillance results and implementing further awareness-raising activities are crucial to address this. Tasks for the future include both raising awareness and the promotion of AMR research and development and international cooperation. The government's next Action Plan, which will detail future countermeasures against AMR based on the outcomes of and tasks identified in the current Action Plan, has been delayed due to the COVID-19 pandemic and is urgently awaited.
抗菌药物耐药性（AMR）带来的威胁持续加剧。日本2016年制定的《国家抗菌药物耐药性行动计划》针对六个领域，已对实施的AMR应对措施产生重大影响。在AMR相关监测方面取得了显著进展，我们现在了解该国抗菌药物使用和抗菌耐药菌的情况。针对医疗专业人员和公众的教育及提高认识活动已积极开展，似乎有助于逐步走向抗菌药物的合理使用。然而，公众对该问题的认识仍不足。确定如何利用监测结果并开展进一步的提高认识活动对于解决这一问题至关重要。未来的任务包括提高认识以及促进AMR研发和国际合作。政府的下一个行动计划将根据当前行动计划的成果和确定的任务详细说明未来针对AMR的应对措施，由于新冠疫情已推迟，人们迫切期待该计划出台。
